25 Posts Not To Miss From ASCO 2026 Day 4
Yvonne Awards 2026 Honored Leaders Shaping the Future of Oncology
AEGEAN Trial: Durvalumab Reshapes the Tumor Microenvironment in Resectable NSCLC
International Partnerships Aim to Mitigate Cancer Care Disruptions in Ukraine - AACR
A Year to Remember at ASCO 26 - GI Cancers Alliance
HARMONi-6 Trial at ASCO Plenary 2026: Ivonescimab Plus Chemotherapy Improves Overall Survival in Advanced Squamous Non-Small Cell Lung Cancer
Is RAS No Longer Undruggable? Discussions on RASolute Trial That Earned Standing Ovation at ASCO26
New Trial Tests Trabectedin With Radiotherapy in Retroperitoneal L-Sarcoma
